New EMA powers have come into force

The European Medicine Agency’s new role in European crisis preparedness was tested during the Covid-19 pandemic, and has now been made permanent.
Photo: KAI PFAFFENBACH/REUTERS / X00446
Photo: KAI PFAFFENBACH/REUTERS / X00446
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

On March 1, EU Regulation to extend the European Medicines Agency’s (EMA) mandate came into effect, meaning that the agency’s more improvised role during the Covid-19 pandemic has now been set in stone.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading